- Country: Ukraine
- Summary: According to Dk 021: 2015 Unified Purchasing Dictionary under Code 33690000-3 Medicines are Different (33696000-5 Reagents and Contrast Substances-33696500-0 Laboratory Reagents: According to the Code Nc 024: 2023 Classif ...
- UAT Ref No: 119670871
- Deadline: 30 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 556370
- Notice Type: Tender
- Document Ref. No.: UA-2025-05-22-008997-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- According to DK 021: 2015 of the Unified Purchase Dictionary under code 33690000-3 Medicines are different (33696000-5 reagents and contrast agents-33696500-0-0 Laboratory reagents: according to the code NC 024: 2023 Classifier of medical products-56988. (Diagnosisin vitro), antibodies; 56954 CD20 IVD cell marker (in vitro diagnosis), antibodies; 56926 CD3 IVD cell marker (in vitro diagnosis), antibodies; 56938 CD10 IVD cell marker (in vitro diagnosis), antibodies; 56930 CD5 IVD cell marker (in vitro diagnosis), antibodies; 56960 CD23 cellularIVD marker (in vitro diagnosis), antibodies; 57069 cyclin D1 IVD (diagnosis in vitro), antibodies; 56823 BCL-2 IVD (diagnostics in vitro), antibodies; 56828 BCL-6 IVD protein (in vitro diagnosis), antibodies; 56968 CD30 IVD cell marker (in vitro diagnosis), antibodies; 57010 Cellular markerCD68 IVD (in vitro diagnosis), antibodies; 56978 CD38 IVD cell marker (in vitro diagnosis), antibodies; 57036 cellular marker CD138 IVD (diagnosis in vitro), antibodies; 57074 Pancytoceratic mixture of antibodies IVD (diagnosis in vitro), antibodies; 63066 free (unrelated) specific antigenprostates (PSA) IVD (diagnosis in vitro), antibodies; 57403 IVD melanosomes (diagnosis in vitro), antibodies; 57393 MELAN-A/MART-1 IVD Peptid (in vitro diagnosis), antibodies; 62812 OCT-3/4, IVD protein (in vitro diagnosis), antibodies; 56770 Alpha-Fetoprotein (AFP) IVD (diagnosis in v ...
Type of procurement:Products
DK 021: 2015: 33600000-6: Pharmaceutical products
Antibodies to CD45, antibodies to CD20, antibodies to CD3. Antibodies to CD30., Antibodies to CD68., Antibodies to CD38., Antibodies toCD138., Antibodies to CK AE1/AE3., Antibodies to PSA., Antibodies to HMB-45., Antibodies to Melan-A., Antibodies to OCT-4., Antibodies to alpha-fetoprotein. SMA., Antibodies to CD34., Antibodies to Vimentin., Antibodies to CD99., Antibodies toP63., Antibodies to P53., Antibodies to P16ink4A., Antibodies to P40., Antibodies to androgen., Antibodi... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAccording to Dk 021: 2015 Unified Purchasing Dictionary under Code 33690000-3 Medicines are Different (33696000-5 Reagents and Contrast Substances-33696500-0 Laboratory Reagents: According to the Code Nc 024: 2023 Classif ... - Ukraine Tender
The MUNICIPAL NON -COMMERCIAL ENTERPRISE KYIV CITY CLINICAL ONCOLOGICAL CENTER OF THE EXECUTIVE BODY OF THE KYIV CITY COUNCIL (KYIV CITY STATE ADMINISTRATION)., a Government sector organization in Ukraine, has announced a new tender for According to Dk 021: 2015 Unified Purchasing Dictionary under Code 33690000-3 Medicines are Different (33696000-5 Reagents and Contrast Substances-33696500-0 Laboratory Reagents: According to the Code Nc 024: 2023 Classif .... This tender is published on UkraineTenders under UAT Ref No: 119670871 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-30.
The estimated tender value is UAH 556370, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
